Cadrenal Therapeutics, Inc.

Nasdaq:CVKD

Pharmaceutical Preparations·PONTE VEDRA, FL

CEO

Pham Quang X

CFO

Szot Matthew K

Financials

12 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/13/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/7/24	→
↓

Earnings Releases (8-K)

10 shown

Filed	Period
11/10/25	Q4 FY2025	→
8/11/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/13/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
8/8/24	Q3 FY2024	→
↓

News (8-K)

36 shown

Filed	Type	Description
2/24/26	Other	Other Events	→
12/23/25	Other	Other Events	→
12/16/25	Agreement	Entry into a Material Definitive Agreement	→
12/11/25	Agreement	Entry into a Material Definitive Agreement	→
12/1/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/18/25	Other	Other Events	→
↓

Prospectuses & Registrations

31 shown

Filed	Form	Description
1/2/26	424B3	424B3	→
12/29/25	S-1	REGISTRATION STATEMENT	→
12/23/25	424B5	PROSPECTUS SUPPLEMENT	→
12/16/25	424B5	PROSPECTUS SUPPLEMENT	→
12/16/25	424B5	PROSPECTUS SUPPLEMENT	→
11/18/25	424B5	PROSPECTUS SUPPLEMENT	→
↓

Filing History(221 filings)

TypeDateAccessionPeriodSize

8-K

Feb 24, 2026

0001213900-26-019606CURRENT REPORT

Feb 24, 2026

219.7 KB

424B3

Jan 2, 2026

0001213900-26-000448PROSPECTUS

—

194.7 KB

EFFECT

Dec 31, 2025

9999999995-26-000024

—

1.7 KB

Dec 31, 2025

0001213900-25-127129

—

12.7 KB

Dec 31, 2025

0001213900-25-127110

Dec 29, 2025

5.1 KB

144

Dec 29, 2025

0001950047-25-010733

—

8.8 KB

S-1

Dec 29, 2025

0001213900-25-125526REGISTRATION STATEMENT

—

430.8 KB

8-K

Dec 23, 2025

0001213900-25-125433CURRENT REPORT

Dec 23, 2025

213.4 KB

424B5

Dec 23, 2025

0001213900-25-125427PROSPECTUS SUPPLEMENT

—

14.9 KB

8-K

Dec 16, 2025

0001213900-25-121932CURRENT REPORT

Dec 15, 2025

793.9 KB

424B5

Dec 16, 2025

0001213900-25-121930PROSPECTUS SUPPLEMENT

—

443.3 KB

424B5

Dec 16, 2025

0001213900-25-121928PROSPECTUS SUPPLEMENT

—

19.3 KB

8-K

Dec 11, 2025

0001213900-25-120360CURRENT REPORT

Dec 10, 2025

17.8 MB

Dec 3, 2025

0001213900-25-118003

Dec 2, 2025

5.5 KB

Dec 3, 2025

0001213900-25-118002

Nov 24, 2025

10.3 KB

8-K

Dec 1, 2025

0001213900-25-116307CURRENT REPORT

Nov 24, 2025

208.6 KB

8-K

Nov 18, 2025

0001213900-25-112123CURRENT REPORT

Nov 18, 2025

214.6 KB

424B5

Nov 18, 2025

0001213900-25-112118PROSPECTUS SUPPLEMENT

—

411.1 KB

8-K

Nov 10, 2025

0001213900-25-107949CURRENT REPORT

Nov 10, 2025

262.5 KB

10-Q

Nov 10, 2025

0001213900-25-107816QUARTERLY REPORT

Sep 30, 2025

3.8 MB

Oct 28, 2025

0001213900-25-103147

Oct 24, 2025

6.2 KB

Oct 28, 2025

0001213900-25-103146

Oct 24, 2025

8.1 KB

144

Oct 27, 2025

0001950047-25-008208

—

11.6 KB

144

Oct 27, 2025

0001628280-25-046441

—

10.4 KB

144

Oct 24, 2025

0001628280-25-046296

—

9.8 KB

25 filings shown

Filed	Form	Description
7/31/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
7/31/25	DEF 14A	DEF 14A	→
6/12/24	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
6/11/24	DEF 14A	DEF 14A	→
5/29/24	PRE 14A	PRE 14A	→
8/31/23	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
↓

Cadrenal Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(221 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/31/25	4	4	→
12/3/25	4	4	→
12/3/25	3	3	→
10/28/25	4	4	→
10/28/25	4	4	→
10/14/25	4	OWNERSHIP DOCUMENT	→
↓